EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Residual cardiovascular disease risk in heart failure patients. What is the real role of lipid-lowering therapy?

Authors

Chrysohoou, Christina; Tsioufis, Kostas P.

Abstract

The article explores the use of lipid-lowering therapy in heart failure patients. It acknowledges that while it is recommended as part of treatment, there is inconclusive evidence regarding its effectiveness, particularly in advanced cases. The article also discusses the potential benefits and risks of statin use, including its impact on muscle strength and energy metabolism. It highlights the need for further research to better understand the role of lipid-lowering therapy in heart failure patients. Additionally, the article mentions new treatments that may be beneficial for hyperlipidemic patients with heart failure. Overall, the article emphasizes the importance of modifying lipid levels in heart failure patients for the prevention of cardiovascular disease.

Subjects

HEART failure; SCIENTIFIC knowledge; HEART failure patients; NICOTINAMIDE adenine dinucleotide phosphate; HEART metabolism disorders; MEDICAL sciences

Publication

Archives of Medical Science, 2024, Vol 20, Issue 4, p1358

ISSN

1734-1922

Publication type

Academic Journal

DOI

10.5114/aoms/190351

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved